Robert A. Figlin
Cedars-Sinai Medical Center(US)Palmetto Hematology Oncology(US)Sinai Health System(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Renal and related cancers, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma(2007)5,732 cited
- → Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma(2007)3,641 cited
- → Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial(2008)3,002 cited
- → Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma(2009)2,185 cited
- → Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma(2005)1,630 cited
- → Phase 3 trial of everolimus for metastatic renal cell carcinoma(2010)1,140 cited